Mark Allen Bach

CIK 1962610 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 2, 2023 · Latest: Feb. 2, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Feb. 7, 2023 GPCR P 1,500 $15.00 $22,500 1,500 Direct Acquired 255.0% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 7, 2023 GPCR American Depositary Shares Ordinary Shares (4,500) 1,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Feb. 2, 2023 GPCR Stock option (right to buy)→ Ordinary Shares (581,610) 581,610 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

GPCR

M.D., Ph.D. Chief Medical Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $466,375 $149,499 $12,500 $628,374

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.